Needham & Company Senior Analyst Mike Matson reported Stryker's plan to acquire Wright Medical Group will face antitrust issues, according to a report from Seeking Alpha.
Three quick notes:
1. The antitrust issues stem from the foot and ankle offerings, since Wright Medical focuses on the lower extremities and small bones.
2. Larry Biegelsen, a senior analyst at Wells Fargo, thinks Stryker will divest Wright Medical's STAR ankle business, which has 70 percent share in the total ankle replacement market.
3. Premarket on Nov. 4, Wright Medical stock was up 31 percent while Stryker was down 3 percent.